Yesterday, the #lifescience team Caixa Capital Risc (Ruben Sebastian, Pablo Cironi, Salvatore Cappadona, Sebastián) enjoyed at the the #BBQ2023 @CataloniaBioHT, one of the most influent events in the #biomedical and health #startup ecosystem in Catalonia.👏

#Inversiones💰 #Inari levanta 4,85 millones de euros en una ronda de inversión liderada por Caixa Capital Risc ¡Enhorabuena! 🔗elreferente.es/inversiones/in…

💰 Caixa Capital Risc lidera una ronda de 4,85 millones que se destinará a acelerar el crecimiento internacional de la compañía @inari_io, que ha desarrollado una plataforma de tecnología 'blockchain' para el sector asegurador. thenewbarcelonapost.com/caixa-capital-…

#inversiones💵 Caixa Capital Risc lidera una ronda de 27M€ en AbolerIS Pharma para avanzar terapias contra enfermedades autoinmunes 👇🏻👇🏻 elreferente.es/inversiones/ca…

Codee cierra una ronda de €5 millones liderada por Swanlaab Venture Factory . Participan también Caixa Capital Risc , UNIRISCO, Armilar Venture Partners, Kfund y Xesgalicia capital-riesgo.es/es/articles/co…

🚀Exciting news! Codee raises 5M€ in a #funding round led by Swanlaab Venture Factory Venture Factory. It also features the continued support of current investors Caixa Capital Risc, Unirisco, Xesgalicia, Armilar, and Kfund . 🔗Read more: codee.com/codee-raises-5… #software #performance

We welcome AbolerIS Pharma to our portfolio! Criteria Bio Ventures Caixa Capital Risc has led a €27.3M Series A in AbolerIS, a Belgian #biotech advancing a groundbreaking autoimmune disease treatment into clinical trials. #CCRbiotech #CBVnews #portfolionews shorturl.at/yDJQ9

We are delighted to share that we have been part of a new #round with Criteria Venture Tech, in Codee, a startup in which we invested in its early stages. 👉Know more about the first Spanish #software development platform specialised in performance. n9.cl/5t4xd

Yesterday, our Biotech Associate Ruben Sebastian took part in a round table on Successfully Navigating Biotech-Pharma Partnerships at #BioSpain2023. Thanks for such an interesting meeting 🙌 BIOSPAIN #CCRbiotech #CBVnews

This week our Bio team had the opportunity to participate in #Biospain2023, an event where we have met with relevant actors of the biotech sector and which strengthens the relationships between the different actors. We would like to thank all the organisers for this opportunity.

🗓️Criteria BIO Ventures team will be at #BIOEurope in Munich to meet biotech entrepreneurs, and catch up with industry leaders and fellow VC investors. We look forward to connecting with #biopharma colleagues, so get in touch with us to arrange a meet up!🤝 #biotechVC #CCRbiotech

I'll be attending this year's #BIOEurope! Feel free to reach out if you want to meet up. See you all in Munich!

Sanofi Laia Pascual Ship2B Ventures Luis Pareras MD, PhD Caixa Capital Risc 6/ 🤩 What makes a project successful in front of others? Pablo Cironi, Director of Life Science Investments at Caixa Capital Risc, explains!📽️👇 📍 During the investment round table of the #CaixaImpulse Innovation training.

We are launching new X profiles! From today we will share our #VC activity on #Tech topics from the account Criteria Venture Tech. Everything related to #Biotech and #LifeSciences will be available at Criteria Bio Ventures. Follow us ⬇️! 🔬goo.su/N3bW2 🤖goo.su/m60dOF

Meet our Criteria Venture Tech team. From this new X account we will inform you about everything related to our #tech portfolio. Don't miss it! Visit the new web ➡️goo.su/K6E7

Meet the Criteria Bio Ventures team! Stay informed about the latest news from our portfolio. Follow us on this new account for updates on our #biotech and #lifesciences investments and team activities! Criteria Bio Ventures web➡️ goo.su/N3bW2 #biotech #lifesciences #pharma